Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $670,320 - $760,914
-6,300 Reduced 12.73%
43,200 $5,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $163,680 - $180,192
-1,600 Reduced 3.13%
49,500 $5,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $3.3 Million - $5 Million
51,100 New
51,100 $3.89 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.